PERSPECTIVE article

Front. Cell Dev. Biol.

Sec. Membrane Traffic and Organelle Dynamics

Volume 13 - 2025 | doi: 10.3389/fcell.2025.1610207

This article is part of the Research Topic2024 International Lowe Syndrome Symposium: Advances and ProceedingsView all articles

Lowe Syndrome and Me: a co-creation video series connecting patients, caregivers, and researchers

Provisionally accepted
Theresa  HaugenTheresa Haugen1,2*Jennifer  Louise GallopJennifer Louise Gallop3*Helene  DoerflingerHelene Doerflinger3
  • 1The Art of Education University, Osaga, Iowa, USA, Osaga, United States
  • 2Lowe Syndrome Association, Ohio, United States
  • 3University of Cambridge, Cambridge, United Kingdom

The final, formatted version of the article will be published soon.

Lowe syndrome (LS) is a rare genetic disorder leading to significant physical and cognitive impairments. Recognizing the need to bridge the gap between researchers and the LS community, a collaborative patient and public involvement (PPI) project, Lowe Syndrome & Me, was initiated. This initiative aimed to foster understanding, improve communication, and strengthen advocacy through a co-created video series. Researchers from the Gurdon Institute (UK) and caregivers from the Lowe Syndrome Association (USA) collaborated to develop a series of videos capturing the unique perspectives of patients and their families, advocacy group members, and researchers. Participants received video production and scriptwriting training, ensuring authentic representation and shared ownership of the content. The videos were disseminated through social media, research institute and patient group websites in the USA, UK and France, raising awareness and improving engagement within the LS community. Feedback from participants highlighted high satisfaction, increased understanding of research, and enhanced communication skills. Challenges included geographical barriers and limited participant diversity, but the project successfully fostered reciprocal learning and strengthened advocacy networks. This case illustrates how meaningful PPI can empower patient communities, enhance research relevance, and promote broader public awareness of rare diseases.

Keywords: co-creation, Patient involvement, Actin, phosphatidylinositol (4, 5) bisphosphate, Lowe syndrome

Received: 11 Apr 2025; Accepted: 26 May 2025.

Copyright: © 2025 Haugen, Gallop and Doerflinger. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Theresa Haugen, The Art of Education University, Osaga, Iowa, USA, Osaga, United States
Jennifer Louise Gallop, University of Cambridge, Cambridge, United Kingdom

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.